Russian coronavirus vaccine produces immune response in early trials



A coronavirus vaccine candidate developed in Russia prompted an immune response and didn’t cause serious adverse reactions in early trials, according to new data released today (Sept. 4).

This data was released weeks after Russia announced that it had approved its vaccine for the general population (but had actually only approved it for a small group of people), Live Science reported,  drawing criticism from public health experts who said there was not enough data to prove the vaccine was safe and effective.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

error

Enjoy this blog? Please spread the word :)

Follow by Email
LinkedIn
Share
Instagram